Amalgamated Bank’s RxSight RXST Stock Holding History

Amalgamated Bank’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,094	Closed	-$11K	–	2591
2025 Q4	$11K	Sell	1,094 -163	-13%	-$1.64K	﹤0.01%	2391
2025 Q3	$11K	Hold	1,257	–	–	﹤0.01%	2432
2025 Q2	$16K	Hold	1,257	–	–	﹤0.01%	2213
2025 Q1	$32K	Buy	1,257 +80	+7%	+$2.38K	﹤0.01%	1919
2024 Q4	$40K	Hold	1,177	–	–	﹤0.01%	1891
2024 Q3	$58K	Hold	1,177	–	–	﹤0.01%	1807
2024 Q2	$71K	Buy	1,177 +207	+21%	+$11.8K	﹤0.01%	1784
2024 Q1	$50K	Sell	970 -3,178	-77%	-$156K	﹤0.01%	1870
2023 Q4	$167K	Buy	4,148 +298	+8%	+$8.74K	﹤0.01%	1850
2023 Q3	$107K	Hold	3,850	–	–	﹤0.01%	1971
2023 Q2	$111K	Buy	3,850 +734	+24%	+$16.3K	﹤0.01%	2027
2023 Q1	$52K	Sell	3,116 -145	-4%	-$2.05K	﹤0.01%	2295
2022 Q4	$41K	Hold	3,261	–	–	﹤0.01%	2514
2022 Q3	$39K	Buy	3,261 +47	+1%	+$645	﹤0.01%	2565
2022 Q2	$45K	Buy	3,214 +1,142	+55%	+$15.1K	﹤0.01%	2544
2022 Q1	$26K	Buy	+2,072	New	+$24.9K	﹤0.01%	2723

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Amalgamated Bank's RXST Position: Q1 2026 in Review

Amalgamated Bank sold out of RxSight (RXST) in Q1 2026, closing a stake of 1,094 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in RXST in Q1 2022 and held it in 16 quarters. The position peaked at $167K in Q4 2023. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Amalgamated Bank reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 1,094 RxSight shares in Q1 2026, an estimated $11K.
Amalgamated Bank first reported a position in RxSight in Q1 2022 and held it in 16 quarters.
Amalgamated Bank's RxSight position peaked at $167K in Q4 2023.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.